Urszula Farooqui-Stopka
43-45 Foley Street, W1W 7TS
London, ENG, United Kingdom
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Combining tissue biomarkers with mpMRI to diagnose clinically significant prostate cancer. Analysis of 21 biomarkers in the PICTURE study.
Journal: Prostate cancer and prostatic diseases
Published: November 08, 2023
Prostate MR image quality of apparent diffusion coefficient maps versus fractional intracellular volume maps from VERDICT MRI using the PI-QUAL score and a dedicated Likert scale for artefacts.
Journal: European journal of radiology
Published: April 07, 2023
Accurate diagnosis of prostate cancer by combining Proclarix with magnetic resonance imaging.
Journal: BJU international
Published: March 01, 2023
ST6GAL1-mediated aberrant sialylation promotes prostate cancer progression.
Journal: The Journal of pathology
Published: February 28, 2023
Upregulation of GALNT7 in prostate cancer modifies O-glycosylation and promotes tumour growth.
Journal: Oncogene
Published: September 22, 2022
Evaluation of PSA and PSA Density in a Multiparametric Magnetic Resonance Imaging-Directed Diagnostic Pathway for Suspected Prostate Cancer: The INNOVATE Trial.
Journal: Cancers
Published: March 05, 2021
Author Correction: Co-targeting PIM and PI3K/mTOR using multikinase inhibitor AUM302 and a combination of AZD-1208 and BEZ235 in prostate cancer.
Journal: Scientific reports
Published: November 12, 2020
Co-targeting PIM and PI3K/mTOR using multikinase inhibitor AUM302 and a combination of AZD-1208 and BEZ235 in prostate cancer.
Journal: Scientific reports
Published: April 16, 2020
Showing 1-11 of 11
Last Updated: 09/26/2026